The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Sinha Uma since year 2005.
The trader's CIK number is 1742587.
At the time of the last reporting, Sinha Uma was the Chief Scientific Officer of Eidos Therapeutics, Inc. .
(stock ticker symbol EIDX).
See this page for all insider trading activities at Eidos Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-25||EIDX||Eidos Therapeutics, Inc.||Sale||2,500||38.76||96,907|
|2019-07-25||EIDX||Eidos Therapeutics, Inc.||Sale||5,000||36.96||184,790|
|2019-07-01||BBIO||Bridgebio Pharma, Inc.||Buy||14,000||17.00||238,000|
|2019-05-23||EIDX||Eidos Therapeutics, Inc.||Sale||5,000||27.52||137,600|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sinha Uma (Chief Scientific Officer of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.